[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].

Ying-Ying Hu, Xin-Ru Sun, Xiao-Ping Lin, Pei-Yan Liang, Xu Zhang, Wei Fan
{"title":"[Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-up].","authors":"Ying-Ying Hu,&nbsp;Xin-Ru Sun,&nbsp;Xiao-Ping Lin,&nbsp;Pei-Yan Liang,&nbsp;Xu Zhang,&nbsp;Wei Fan","doi":"10.5732/cjc.009.10097","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objective: </strong>Accurate and early diagnosis of recurrence for cervical cancer after the treatment and aggressive salvage treatment could improve the prognosis of this disease. Serum squamous cell carcinoma antigen (SCCAg) is the most commonly used tumor marker for the detection of asymptomatic recurrence of cervical cancer. This study was to evaluate the application and value of (18)F-FDG PET/CT in cervical cancer with elevated of serum SCCAg level during the follow-up.</p><p><strong>Methods: </strong>Thirty-one patients with cervical cancer with elevated serum SCCAg level during the follow-up undergoing (18)F-FDG PET/CT in Sun Yat-sen University Cancer Center between August 2005 and November 2008 were entered into this retrospective study. The pathological types, the serum SCCAg level, PET/CT results, results of other imaging modalities, pathological and clinical follow-ups were recorded.</p><p><strong>Results: </strong>All 31 patients'pathological examination showed squamous cell carcinoma, including three adenosquamous carcinoma. Lesions of all patients were examined by PET/CT. Three patients had local recurrence in the uterus or vagina, 28 had metastatic disease. Of these 31 patients, three were confirmed to have local recurrent disease, 27 were verified to have metastatic disease and one was diagnosed as primary lung squamous cell carcinoma by pathological or clinical manifestations. The total detection rate of PET/CT for malignancy was 100% (31/31); the diagnostic accuracy of PET/CT for recurrent cervical cancer was 96.8% (30/31). The levels of serum SCCAg during the follow-up were 1.5-37.8 ng/ml. There was no relation between the level of serum SCCAg and the maximum standard uptake value (SUVmax) of PET/CT. Compared with other imaging modalities, PET/CT was more efficient in detecting recurrence and finding more lesions.</p><p><strong>Conclusions: </strong>An elevated level of SCCAg in cervical cancer during the follow-up indicates tumor recurrence. PET/CT is efficient in detecting the recurrence and has high diagnostic accuracy.</p>","PeriodicalId":7559,"journal":{"name":"Ai zheng = Aizheng = Chinese journal of cancer","volume":"28 9","pages":"994-9"},"PeriodicalIF":0.0000,"publicationDate":"2009-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ai zheng = Aizheng = Chinese journal of cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5732/cjc.009.10097","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background and objective: Accurate and early diagnosis of recurrence for cervical cancer after the treatment and aggressive salvage treatment could improve the prognosis of this disease. Serum squamous cell carcinoma antigen (SCCAg) is the most commonly used tumor marker for the detection of asymptomatic recurrence of cervical cancer. This study was to evaluate the application and value of (18)F-FDG PET/CT in cervical cancer with elevated of serum SCCAg level during the follow-up.

Methods: Thirty-one patients with cervical cancer with elevated serum SCCAg level during the follow-up undergoing (18)F-FDG PET/CT in Sun Yat-sen University Cancer Center between August 2005 and November 2008 were entered into this retrospective study. The pathological types, the serum SCCAg level, PET/CT results, results of other imaging modalities, pathological and clinical follow-ups were recorded.

Results: All 31 patients'pathological examination showed squamous cell carcinoma, including three adenosquamous carcinoma. Lesions of all patients were examined by PET/CT. Three patients had local recurrence in the uterus or vagina, 28 had metastatic disease. Of these 31 patients, three were confirmed to have local recurrent disease, 27 were verified to have metastatic disease and one was diagnosed as primary lung squamous cell carcinoma by pathological or clinical manifestations. The total detection rate of PET/CT for malignancy was 100% (31/31); the diagnostic accuracy of PET/CT for recurrent cervical cancer was 96.8% (30/31). The levels of serum SCCAg during the follow-up were 1.5-37.8 ng/ml. There was no relation between the level of serum SCCAg and the maximum standard uptake value (SUVmax) of PET/CT. Compared with other imaging modalities, PET/CT was more efficient in detecting recurrence and finding more lesions.

Conclusions: An elevated level of SCCAg in cervical cancer during the follow-up indicates tumor recurrence. PET/CT is efficient in detecting the recurrence and has high diagnostic accuracy.

[18F-FDG PET/CT在随访期间血清鳞状细胞癌抗原升高的宫颈癌中的应用]。
背景与目的:准确、早期诊断宫颈癌治疗后复发及积极的抢救治疗可改善该病的预后。血清鳞状细胞癌抗原(SCCAg)是检测宫颈癌无症状复发最常用的肿瘤标志物。本研究旨在评价(18)F-FDG PET/CT在随访期间血清SCCAg水平升高的宫颈癌中的应用及价值。方法:选取2005年8月至2008年11月中山大学肿瘤中心行(18)F-FDG PET/CT随访时血清SCCAg水平升高的宫颈癌患者31例进行回顾性研究。记录病理分型、血清SCCAg水平、PET/CT及其他影像学检查结果、病理及临床随访情况。结果:31例患者病理检查均为鳞状细胞癌,其中腺鳞癌3例。所有患者均行PET/CT检查病变。子宫或阴道局部复发3例,转移性疾病28例。31例患者中3例确诊为局部复发,27例确诊为转移性疾病,1例经病理或临床表现诊断为原发性肺鳞状细胞癌。PET/CT对恶性肿瘤的总检出率为100% (31/31);PET/CT对复发性宫颈癌的诊断准确率为96.8%(30/31)。随访期间血清SCCAg水平为1.5 ~ 37.8 ng/ml。血清SCCAg水平与PET/CT最大标准摄取值(SUVmax)无相关性。与其他成像方式相比,PET/CT在发现复发和发现更多病变方面更有效。结论:随访期间宫颈SCCAg水平升高提示肿瘤复发。PET/CT检测复发率高,诊断准确率高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信